Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
about
Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to FunctionFrom UBE3A to Angelman syndrome: a substrate perspectiveEpigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.UBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel EndocytosisA novel form of synaptic plasticity in field CA3 of hippocampus requires GPER1 activation and BDNF releaseDissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.Potential therapeutic approaches for Angelman syndrome.Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans.Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.Perturbed proteostasis in autism spectrum disorders.Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.Angelman syndrome: Current and emerging therapies in 2016.mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome miceRapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cellsNovel neurobiological roles of UBE3A.Yin-and-Yang of mTORC1/C2 in Angelman syndrome mice.Pharmacological therapies for Angelman syndrome.Postnatal calpain inhibition elicits cerebellar cell death and motor dysfunction.Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice.UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticityMorphology regulation in vascular endothelial cells
P2860
Q26770762-9BF24847-F430-4D3E-9E07-13F340A5BC31Q26781685-416BA34C-CF89-41B3-BDC2-4B20E274E58AQ30373162-CBCD3535-F84C-42B8-BF71-C2F206314EEEQ35904353-6E4577B3-A59C-4B26-929B-7933B45B64B0Q36102758-03E825D8-FEFA-42DB-B51C-BEEA49BDC1B2Q36266495-68ADD84C-D49B-4C6A-8D3B-24F787F1E999Q36992786-CD53A3C8-F660-46BE-BE17-27413E59C4DAQ37052993-3DDE91CE-DE01-46A4-9DEC-E1E775A7E7A5Q37729341-0C07FF76-42CA-4AD3-90F8-B63ADE11D2D0Q38732547-CB50179F-C041-4D3B-BCA2-C721154E0A1DQ38882773-34F1E9CE-F0AB-4129-9757-84ADCCD993A3Q38893465-8E58F685-9DB6-42E6-9F4E-4C69B723A3FEQ39012491-7E033036-9D52-4E40-9300-E1CF30419391Q41378038-12C68F7E-5164-41B3-8078-AAC2378BEEC1Q42244908-CF47B4EA-8499-46D9-BCB1-6A4C48D07C6EQ42315765-92B212DC-D8AE-4714-8DAD-819CD98EA29AQ42589224-57F76CE8-3F97-4A95-A337-B0AAC4D36FC7Q46368852-2C6D9E74-DBBA-4AFB-AD34-CFB812553EA5Q47121498-578435E2-77AC-41C7-8547-352E71EF1EC2Q47582921-CD054686-14CC-4C1F-97D5-769E60AA2FF8Q56534093-DC9ED659-84BC-4B5A-98DB-3CC2A74CF2EAQ58756704-021C71B4-AEBC-4157-80D2-460406FBE0DC
P2860
Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Imbalanced mechanistic target ...... e mice impairs motor function.
@ast
Imbalanced mechanistic target ...... e mice impairs motor function.
@en
type
label
Imbalanced mechanistic target ...... e mice impairs motor function.
@ast
Imbalanced mechanistic target ...... e mice impairs motor function.
@en
prefLabel
Imbalanced mechanistic target ...... e mice impairs motor function.
@ast
Imbalanced mechanistic target ...... e mice impairs motor function.
@en
P2093
P2860
P1476
Imbalanced mechanistic target ...... e mice impairs motor function.
@en
P2093
Jiandong Sun
Michel Baudry
Stephanie Moreno
Xiaoning Bi
P2860
P304
P356
10.1523/JNEUROSCI.4276-14.2015
P407
P577
2015-03-01T00:00:00Z